Track patient progression from disease population to treatment persistence. Analyze drop-off rates at each stage, identify revenue opportunities, and optimize your patient funnel strategy.
The patient journey funnel maps progression from total disease population through diagnosis, treatment initiation, brand selection, adherence, and long-term persistence. Each stage represents a critical conversion point where patients are gained or lost.
Input your disease population and conversion rates at each stage to analyze your patient journey funnel.
Get our free canvas template to map out your complete patient journey with intervention strategies at each stage.
The patient journey funnel is a critical framework for pharmaceutical brand teams to understand where patients are gained and lost along the treatment pathway. By quantifying each stage from disease prevalence through long-term persistence, teams can identify the highest-impact intervention points and allocate resources more effectively.
| Therapy Area | Adherence (6 mo) | Persistence (12 mo) |
|---|---|---|
| Oncology | 85% | 70% |
| Cardiovascular | 60% | 40% |
| Diabetes | 65% | 45% |
| Respiratory | 55% | 35% |
| Mental Health | 45% | 25% |
Disease Population
The total number of patients living with the disease or condition, including both diagnosed and undiagnosed individuals. This represents the maximum addressable market.
Diagnosis Rate
The percentage of the disease population that has been formally diagnosed. Undiagnosed patients represent a significant untapped opportunity, especially in conditions like NASH, rare diseases, and early-stage cancers.
Treatment Initiation
The percentage of diagnosed patients who begin any form of treatment. Barriers include cost, access, patient reluctance, and physician prescribing patterns.
Adherence vs. Persistence
Adherence measures whether patients take their medication as prescribed (correct dose, frequency). Persistence measures how long patients continue therapy over time. Both are critical for treatment outcomes and brand revenue.
How do I estimate my disease population?
Use epidemiological data from sources like IQVIA, claims databases, or published prevalence studies. Multiply prevalence rate by total population in your target geography.
What is a good brand share for a pharma product?
Brand share varies widely by therapeutic area and competitive landscape. A market leader may hold 30-50% share, while a new entrant may start at 5-10%. The key metric is trajectory rather than absolute share.
How can I improve patient persistence?
Proven strategies include patient support programs (hubs), nurse educator outreach, copay assistance, refill reminders, digital engagement tools, and simplifying treatment regimens.